Procter & Gamble’s (PG) “Buy” Rating Reaffirmed at DA Davidson

Procter & Gamble (NYSE:PGGet Free Report)‘s stock had its “buy” rating restated by investment analysts at DA Davidson in a research note issued on Thursday,Benzinga reports. They currently have a $209.00 price objective on the stock. DA Davidson’s price target would indicate a potential upside of 27.12% from the company’s previous close. DA Davidson also issued estimates for Procter & Gamble’s Q3 2025 earnings at $1.58 EPS.

A number of other research firms also recently commented on PG. Hsbc Global Res upgraded shares of Procter & Gamble to a “strong-buy” rating in a report on Friday, October 4th. Barclays dropped their target price on shares of Procter & Gamble from $163.00 to $155.00 and set an “equal weight” rating on the stock in a research report on Friday, January 17th. Wells Fargo & Company dropped their target price on shares of Procter & Gamble from $190.00 to $176.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 7th. JPMorgan Chase & Co. dropped their target price on shares of Procter & Gamble from $186.00 to $181.00 and set an “overweight” rating on the stock in a research report on Thursday, January 16th. Finally, Stifel Nicolaus dropped their target price on shares of Procter & Gamble from $167.00 to $161.00 and set a “hold” rating on the stock in a research report on Friday, January 17th. Eight research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, Procter & Gamble currently has a consensus rating of “Moderate Buy” and a consensus target price of $180.53.

Read Our Latest Stock Report on Procter & Gamble

Procter & Gamble Stock Down 1.0 %

NYSE PG opened at $164.41 on Thursday. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.76 and a quick ratio of 0.55. The company’s 50 day simple moving average is $168.96 and its 200 day simple moving average is $169.36. Procter & Gamble has a 12 month low of $152.06 and a 12 month high of $180.43. The company has a market capitalization of $387.20 billion, a P/E ratio of 26.18, a PEG ratio of 3.69 and a beta of 0.45.

Procter & Gamble (NYSE:PGGet Free Report) last released its earnings results on Wednesday, January 22nd. The company reported $1.88 EPS for the quarter, topping analysts’ consensus estimates of $1.86 by $0.02. Procter & Gamble had a net margin of 18.35% and a return on equity of 32.88%. The business had revenue of $21.88 billion for the quarter, compared to the consensus estimate of $21,657,595.49 billion. During the same period in the previous year, the firm earned $1.84 EPS. The business’s revenue for the quarter was up 2.1% on a year-over-year basis. Equities research analysts expect that Procter & Gamble will post 6.94 earnings per share for the current fiscal year.

Insider Buying and Selling at Procter & Gamble

In other news, insider Balaji Purushothaman sold 12,800 shares of the business’s stock in a transaction on Thursday, November 21st. The shares were sold at an average price of $172.73, for a total value of $2,210,944.00. Following the completion of the sale, the insider now directly owns 11,595 shares in the company, valued at approximately $2,002,804.35. The trade was a 52.47 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Gary A. Coombe sold 47,847 shares of the business’s stock in a transaction on Wednesday, November 27th. The stock was sold at an average price of $179.84, for a total transaction of $8,604,804.48. Following the completion of the sale, the chief executive officer now owns 39,977 shares of the company’s stock, valued at $7,189,463.68. The trade was a 54.48 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 0.18% of the company’s stock.

Institutional Trading of Procter & Gamble

Institutional investors and hedge funds have recently modified their holdings of the company. Concurrent Investment Advisors LLC lifted its stake in shares of Procter & Gamble by 4.5% in the third quarter. Concurrent Investment Advisors LLC now owns 94,109 shares of the company’s stock worth $16,300,000 after buying an additional 4,035 shares during the last quarter. Copley Financial Group Inc. acquired a new position in Procter & Gamble during the 3rd quarter valued at $668,000. Fortem Financial Group LLC acquired a new position in Procter & Gamble during the 4th quarter valued at $569,000. Nordea Investment Management AB raised its stake in Procter & Gamble by 7.5% during the 4th quarter. Nordea Investment Management AB now owns 2,898,569 shares of the company’s stock valued at $484,583,000 after purchasing an additional 201,695 shares during the last quarter. Finally, Synovus Financial Corp raised its stake in Procter & Gamble by 3.4% during the 3rd quarter. Synovus Financial Corp now owns 185,134 shares of the company’s stock valued at $32,065,000 after purchasing an additional 6,077 shares during the last quarter. 65.77% of the stock is currently owned by institutional investors and hedge funds.

About Procter & Gamble

(Get Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Recommended Stories

Analyst Recommendations for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.